Nephrocare Health IPO Allotment Status to Be Finalised Today; Listing Scheduled for Dec 17

Nephrocare Health Services IPO has reached a key milestone today, December 15, 2025, with the allotment of shares expected to be finalised. 

IPO Structure and Size

The IPO was a book-built issue aggregating to ₹871.05 crore. It comprised a fresh issue of 0.77 crore equity shares worth ₹353.40 crore and an offer for sale of 1.13 crore shares amounting to ₹517.64 crore. 

Subscription Details

The Nephrocare Health IPO received robust demand, closing with an overall subscription of 14.08 times by the end of bidding on December 12, 2025. The qualified institutional buyers category, excluding anchor investors, was subscribed 26.82 times, reflecting strong institutional interest. 

The non-institutional investor segment saw 24.77 times subscription, while the retail investor portion was subscribed 2.36 times.

Price Band and Investment Details

The IPO was priced in the range of ₹438 to ₹460 per share. The lot size was fixed at 32 shares, requiring a minimum retail investment of ₹14,720 at the upper end of the price band. Kfin Technologies Ltd is the registrar to the issue and will be responsible for finalising and communicating the allotment status to investors.

Listing Timeline

Following today’s allotment, successful applicants can expect shares to be credited to their demat accounts shortly. The company’s equity shares are scheduled to list on both the BSE and NSE, with a tentative listing date of December 17, 2025.

About Nephrocare Health Services Ltd

Incorporated in 2010, Nephrocare Health Services Ltd. is a leading dialysis care provider offering comprehensive services including diagnosis, haemodialysis, home and mobile dialysis, wellness programs, and pharmacy support. 

As of September 30, 2025, the company operated 519 clinics, including 51 overseas locations across the Philippines, Uzbekistan, and Nepal. In India, its network spans 288 cities across 21 states and 4 union territories, with over three-fourths of clinics located in tier II and tier III cities.

Also Read: Upcoming IPO: Shivganga Drillers Filed DRHP with SEBI!

Conclusion

With the allotment scheduled for today after a 14.08x subscription, the Nephrocare Health IPO has drawn significant investor attention. The institutional demand and extensive healthcare footprint position the company well as it prepares for its stock market debut later this week.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a private recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.